These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
News Medical on MSN22h
Diabetes medications may help lower COPD flare-up risk, study findsThe study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...
Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...
The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...
Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.
HealthDay News — Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in the Journal of the American Medical Association.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback